Corporate Profile:
Guangdong Huacai Liying Pharmaceutical Manufacturing Co., Ltd. is a core technology-driven enterprise under the Guangdong Xinde Biological Technology Group. With the development core of "Reshaping the boundaries of freeze-drying technology through science and empowering the future of big health through innovation," the company focuses on cutting-edge R&D and intelligent manufacturing of specialty freeze-dried powders. It stands as an innovative benchmark in the pharmaceutical and health fields, with business spanning daily necessities, cosmetics, and health food processing. Owning multiple brands, its product range covers cleansing, skincare, haircare, and freeze-dried powders, while providing professional one-stop OEM/ODM services. The company holds ISO9001:2000 quality management system certification and international GMP certification. It boasts a 50,000-square-meter large-scale production base, Class 100,000 GMP-certified production workshops, large-scale laboratories, and Class 10,000 inspection rooms, equipped with high-efficiency fully automated production equipment and a complete disinfection, sterilization, and professional testing system.
Corporate Philosophy:
(I) Corporate Mission
To make outstanding contributions to human health and beauty.
(II) Corporate Vision
To be a leader in the Chinese cosmetics industry and become a highly respected national enterprise.
(III) Core Values
Respect for customers, people-oriented, win-win collaboration, and rigorous diligence.
Development History:
1984-1994: In 1984, the first Xinde Pharmacy was established in Yangjiang.
1995-1999: The group began to expand, with sales exceeding 20 million RMB for the first time.
2000: Innovative development led to the establishment of several subsidiaries under the group.
2005: Reached strategic technical support with the Hong Kong Xingzhou (Han Medicine) International Research Institute.
2009: Guangdong Xinde Group was recognized as a National High-tech Enterprise.
2012: Reached strategic technical support with the Morita Life Science Research Institute.
2014: The group expanded its OEM/ODM business, becoming one of the top three large-scale OEM factories in the national big health industry.
2016: The group's first e-commerce media company was established in Binjiang District, Hangzhou.
2019: The group began leapfrog development, establishing Guangdong Quanli Pharmaceutical Technology Co., Ltd. to enter the beauty and skincare sector.
2020: The group's first offline physical brand image store entered beauty supermarkets.
2021: Guangdong Quanli Pharmaceutical Technology Co., Ltd. obtained 21 National Special Cosmetic Certificates and purchased two 10-million-level and two million-level pieces of equipment.
2022-2024: The number of offline physical brand image stores reached 22, spread across the country.
October 28, 2025: Guangdong Huacai Liying Pharmaceutical Manufacturing Co., Ltd. opened, marking a further step in the group's development.


